<DOC>
	<DOCNO>NCT00496275</DOCNO>
	<brief_summary>To test safety tolerability ZD6474 combination withVinorelbine ( Navelbine ) Gemcitabine ( Gemzar ) plus cisplatin first line therapy patient locally advanced metastatic ( Stage IIIB-IV ) Non Small Cell Lung Cancer .</brief_summary>
	<brief_title>Phase I Combination With Vinorelbine Gemcitabine Plus Cisplatin Locally Advanced Metastatic NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Confirmed non small cell lung cancer ( stage IIIBIV ) Life expectancy great 12 week At least 1 measurable lesion great 10mm small diameter . Prior treatment anticancer agent Brain metastases Major surgery within last 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>ZACTIMA</keyword>
</DOC>